ANKRD26 and myelodysplastic syndrome: Pathogenic variants typically occur in the 5′ untranslated region (5′UTR) of the gene, causing abnormal upregulation of ANKRD26 in megakaryocytes, defective platelet production, and a cumulative risk of MDS or AML estimated at 8–20% [159,160,161].